{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T18:55:48Z","timestamp":1791572148875,"version":"4.3.4"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1016\/j.jconrel.2006.11.024","type":"journal-article","created":{"date-parts":[[2006,12,6]],"date-time":"2006-12-06T12:11:17Z","timestamp":1165407077000},"page":"387-395","source":"Crossref","is-referenced-by-count":175,"title":["Controlled delivery of recombinant hirudin based on thermo-sensitive Pluronic\u00ae F127 hydrogel for subcutaneous administration: In vitro and in vivo characterization"],"prefix":"10.1016","volume":"117","author":[{"given":"Yu","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Liang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Cheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Qing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-Yan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2006.11.024_bib1","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.1016\/S0142-9612(03)00245-X","article-title":"Improved reverse thermo-responsive polymeric systems","volume":"24","author":"Cohn","year":"2003","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2006.11.024_bib2","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ejpb.2004.03.019","article-title":"In situ-forming hydrogels \u2014 review of temperature-sensitive systems","volume":"58","author":"Ruel-Gari\u00e9py","year":"2004","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2006.11.024_bib3","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/jbm.820060609","article-title":"Artificial skin: I. Preparation and properties of Pluronic F-127 gels for trearment of burns","volume":"6","author":"Schmolka","year":"1972","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/j.jconrel.2006.11.024_bib4","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ijpharm.2004.03.029","article-title":"Effect of anti-inflammatories on Pluronic F127: micellar assembly, gelation and partitioning","volume":"278","author":"Sharma","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2006.11.024_bib5","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0378-5173(99)00307-5","article-title":"Controlled release of vancomycin from poloxamer 407 gels","volume":"192","author":"Veyries","year":"1999","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2006.11.024_bib6","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0378-5173(81)90013-2","article-title":"In vitro release of lidocaine from Pluronic F-127 gels","volume":"8","author":"Chen-Chow","year":"1981","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2006.11.024_bib7","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0168-3659(97)00206-X","article-title":"Controlled release and dura mater permeability of lidocaine and ibuprofen from injectable poloxamer-based gels","volume":"52","author":"Paavola","year":"1998","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2006.11.024_bib8","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0378-5173(98)00074-X","article-title":"Salt effects on the diffusion and release rate of propranolol from poloxamer 407 gels","volume":"167","author":"Pandit","year":"1998","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2006.11.024_bib9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0168-3659(02)00273-0","article-title":"Development and in-vitro evaluation of sustained release poloxamer 407(P407) gel formulations of ceftiofur","volume":"85","author":"Zhang","year":"2002","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2006.11.024_bib10","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1023\/A:1015815624334","article-title":"Sustained delivery of interleukin-2 from a poloxamer 407 gel matrix following intraperitoneal injection in mice","volume":"9","author":"Johnston","year":"1992","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2006.11.024_bib11","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/jps.2600810707","article-title":"Biological activity of urease formulated in poloxamer 407 after intraperitoneal injection in the rat","volume":"81","author":"Pec","year":"1992","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2006.11.024_bib12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0168-3659(02)00271-7","article-title":"Pluronic\u00ae F127 gel formulations of deslorelin and GnRH reduce drug degradation and sustain drug release and effect in cattle","volume":"85","author":"James","year":"2002","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2006.11.024_bib13","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1021\/js970034d","article-title":"Drug delivery matrix containing native protein precipitates suspended in a poloxamer gel","volume":"86","author":"Stratton","year":"1997","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2006.11.024_bib14","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/jps.2600840609","article-title":"Effect of surfactants on the physical stability of rhGH","volume":"84","author":"Katakam","year":"1995","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2006.11.024_bib15","first-page":"83","article-title":"Toxicological evaluation of poloxamer vehicles for intramuscular use","volume":"39","author":"Johnston","year":"1985","journal-title":"J. Parenter. Sci. Technol."},{"key":"10.1016\/j.jconrel.2006.11.024_bib16","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1126\/science.2374926","article-title":"The structure of a complex of recombinant hirudin and human \u03b1-thrombin","volume":"249","author":"Rydel","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2006.11.024_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0049-3848(94)90032-9","article-title":"The development of hirudin as an antithrombotic drug","volume":"74","author":"Markwardt","year":"1994","journal-title":"Thromb. Res."},{"key":"10.1016\/j.jconrel.2006.11.024_bib18","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0049-3848(93)90023-H","article-title":"Studies on the pharmacokinetics and pharmacodynamics of recombinant hirudin (rHV2-Lys47) after intravenous and subcutaneous administration in dogs","volume":"69","author":"Lyer","year":"1993","journal-title":"Thromb. Res."},{"key":"10.1016\/j.jconrel.2006.11.024_bib19","first-page":"237","article-title":"Studies on pharmacokinetics of hirudin","volume":"46","author":"Markwardt","year":"1987","journal-title":"Biomed. Biochim. Acta"},{"key":"10.1016\/j.jconrel.2006.11.024_bib20","first-page":"202","article-title":"Pharmacological survey of recombinant hirudin","volume":"43","author":"Markwardt","year":"1988","journal-title":"Pharmazie"},{"key":"10.1016\/j.jconrel.2006.11.024_bib21","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.peptides.2004.10.003","article-title":"Pharmacodynamics and pharmacokinetics of recombinant hirudin via four non-parenteral routes","volume":"26","author":"Liu","year":"2005","journal-title":"Peptides"},{"issue":"11","key":"10.1016\/j.jconrel.2006.11.024_bib22","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1111\/j.1745-7254.2005.00174.x","article-title":"Permeation-enhancing effects of chitosan formulations on recombinant hirudin-2 by nasal delivery in vitro and in vivo","volume":"26","author":"Zhang","year":"2005","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.jconrel.2006.11.024_bib23","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1124\/jpet.103.056655","article-title":"Gastrointestinal absorption of recombinant hirudin-2 in rats","volume":"308","author":"Yan","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jconrel.2006.11.024_bib24","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.peptides.2005.08.015","article-title":"Investigation on recombinant hirudin via oral route","volume":"27","author":"Cen","year":"2006","journal-title":"Peptides"},{"key":"10.1016\/j.jconrel.2006.11.024_bib25","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.1016\/S0142-9612(02)00208-9","article-title":"Effect of mammalian cell culture medium on the gelation properties of Pluronic PF127","volume":"23","author":"Matthew","year":"2002","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2006.11.024_bib26","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1006\/jcis.1997.4880","article-title":"Study of the gelation process of polyethylene oxidea-polypropylene oxideb-polyethylene oxidea copolymer","volume":"190","author":"Cabana","year":"1997","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.jconrel.2006.11.024_bib27","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0927-7757(00)00493-3","article-title":"Effect of additives on the micellization of PEO\/PPO\/PEO block copolymer PF127 in aqueous solution","volume":"178","author":"Desai","year":"2001","journal-title":"Colloids Surf., A Physicochem. Eng. Asp."},{"key":"10.1016\/j.jconrel.2006.11.024_bib28","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0378-5173(99)00119-2","article-title":"Absorption of insulin from Pluronic F-127 gels following subcutaneous administration in rats","volume":"184","author":"Barichello","year":"1999","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2006.11.024_bib29","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/0049-3848(85)90023-4","article-title":"Assay of hirudin in plasma using a chromogenic thrombin substrate","volume":"37","author":"Griebach","year":"1985","journal-title":"Thromb. Res."},{"key":"10.1016\/j.jconrel.2006.11.024_bib30","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0378-5173(00)00589-5","article-title":"Micellization and gelation in block copolymer systems containing local anesthetics","volume":"211","author":"Scherlund","year":"2000","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2006.11.024_bib31","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0378-5173(96)04748-5","article-title":"Loss of gelation ability of Pluronic\u00ae F127 in the presence of some salts","volume":"145","author":"Pandit","year":"1996","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2006.11.024_bib32","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.1021\/ma00093a016","article-title":"Phase diagrams and aggregation behavior of poly(oxyethylene)\u2013poly(oxypropylene)\u2013poly(oxyethylene) triblock copolymes in aqueous solutions","volume":"27","author":"Wanka","year":"1994","journal-title":"Macromolecules"},{"key":"10.1016\/j.jconrel.2006.11.024_bib33","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1163\/1568562054798545","article-title":"Structure and assembly of PEO\u2013PPO\u2013PEO co-polymers in mammalian cell-culture media","volume":"16","author":"Sharma","year":"2005","journal-title":"J. Biomater. Sci., Polym. Ed."},{"key":"10.1016\/j.jconrel.2006.11.024_bib34","doi-asserted-by":"crossref","first-page":"5440","DOI":"10.1021\/ma00046a049","article-title":"Self-assembly in aqueous block copolymer solutions","volume":"25","author":"Malmsten","year":"1992","journal-title":"Macromolecules"},{"key":"10.1016\/j.jconrel.2006.11.024_bib35","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.colsurfa.2004.11.020","article-title":"Propofol induced micelle formation in aqueous block copolymer solutions","volume":"254","author":"Dwyer","year":"2005","journal-title":"Colloids Surf., A Physicochem. Eng. Asp."},{"key":"10.1016\/j.jconrel.2006.11.024_bib36","doi-asserted-by":"crossref","first-page":"10839","DOI":"10.1016\/S0021-9258(18)99095-2","article-title":"Stability of hirudin, a thrombin-specific inhibitor","volume":"266","author":"Chang","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2006.11.024_bib37","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0378-5173(96)04649-2","article-title":"Comparative analysis of tetracycline-containing dental gels: poloxamer- and monoglycerude-based formulations","volume":"142","author":"Esposito","year":"1996","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2006.11.024_bib38","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1023\/A:1016264527738","article-title":"Controlled release of lidocaine from injectable gels and efficacy in rat sciatic nerve block","volume":"12","author":"Paavola","year":"1995","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2006.11.024_bib39","first-page":"88","article-title":"Structural analysis of hirudin using FT-IR and FT-Raman spectroscopic techniques","volume":"19","author":"Aminzadeh","year":"2000","journal-title":"Iran. J. Chem. Chem. Eng."},{"key":"10.1016\/j.jconrel.2006.11.024_bib40","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1081\/PDT-120003487","article-title":"Intratumoral administration of paclitaxel in an in situ gelling poloxamer 407 formulation","volume":"7","author":"Amiji","year":"2002","journal-title":"Pharm. Dev. Technol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365906006924?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365906006924?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T13:58:47Z","timestamp":1628171927000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365906006924"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["S0168365906006924"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2006.11.024","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]}}}